These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

883 related items for PubMed ID: 27793005

  • 1. Methylation-associated silencing of microRNA-129-3p promotes epithelial-mesenchymal transition, invasion and metastasis of hepatocelluar cancer by targeting Aurora-A.
    Cui S, Zhang K, Li C, Chen J, Pan Y, Feng B, Lu L, Zhu Z, Wang R, Chen L.
    Oncotarget; 2016 Nov 22; 7(47):78009-78028. PubMed ID: 27793005
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY, Zhang K, Chen DQ, Chen J, Feng B, Song H, Chen Y, Zhu Z, Lu L, De W, Wang R, Chen LB.
    Oncotarget; 2015 Jul 30; 6(21):18613-30. PubMed ID: 26164082
    [Abstract] [Full Text] [Related]

  • 3. miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4.
    Dou C, Liu Z, Xu M, Jia Y, Wang Y, Li Q, Yang W, Zheng X, Tu K, Liu Q.
    Cancer Lett; 2016 Oct 28; 381(2):380-90. PubMed ID: 27544906
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q, Liu X, Liu Z, Zhou Z, Wang Y, Tu J, Li L, Bao H, Yang L, Tu K.
    Mol Cancer; 2017 Jun 12; 16(1):103. PubMed ID: 28606154
    [Abstract] [Full Text] [Related]

  • 5. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
    Zhao N, Sun H, Sun B, Zhu D, Zhao X, Wang Y, Gu Q, Dong X, Liu F, Zhang Y, Li X.
    Sci Rep; 2016 Mar 16; 6():23091. PubMed ID: 26980408
    [Abstract] [Full Text] [Related]

  • 6. Upregulation of microRNA-140-3p inhibits epithelial-mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN.
    Zhang QY, Men CJ, Ding XW.
    J Cell Biochem; 2019 Sep 16; 120(9):14885-14898. PubMed ID: 31044454
    [Abstract] [Full Text] [Related]

  • 7. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
    Xie Y, Du J, Liu Z, Zhang D, Yao X, Yang Y.
    J Exp Clin Cancer Res; 2019 Jan 08; 38(1):7. PubMed ID: 30621734
    [Abstract] [Full Text] [Related]

  • 8. MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C.
    Tao J, Liu Z, Wang Y, Wang L, Yao B, Li Q, Wang C, Tu K, Liu Q.
    Biomed Pharmacother; 2017 Sep 08; 93():420-428. PubMed ID: 28666208
    [Abstract] [Full Text] [Related]

  • 9. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R, Yu Z, Chen F, Xu H, Shen S, Chen W, Chen L, Su Q, Zhang L, Bi J, Zeng W, Li W, Huang X, Wang Q.
    Biomed Pharmacother; 2018 Jul 08; 103():1632-1642. PubMed ID: 29864952
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. microRNA-501-3p suppresses metastasis and progression of hepatocellular carcinoma through targeting LIN7A.
    Luo C, Yin D, Zhan H, Borjigin U, Li C, Zhou Z, Hu Z, Wang P, Sun Q, Fan J, Zhou J, Wang X, Zhou S, Huang X.
    Cell Death Dis; 2018 May 01; 9(5):535. PubMed ID: 29749382
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase.
    Chang RM, Yang H, Fang F, Xu JF, Yang LY.
    Hepatology; 2014 Oct 01; 60(4):1251-63. PubMed ID: 24825302
    [Abstract] [Full Text] [Related]

  • 14. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
    He C, Liu Z, Jin L, Zhang F, Peng X, Xiao Y, Wang X, Lyu Q, Cai X.
    Cell Physiol Biochem; 2018 Oct 01; 48(5):1928-1941. PubMed ID: 30092578
    [Abstract] [Full Text] [Related]

  • 15. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M, Xue H, Wang Y, Shen Q, Jiang Q, Zhang X, Li K, Jia M, Jia J, Xu J, Tian Y.
    Int J Oncol; 2017 Mar 01; 50(3):975-983. PubMed ID: 28098858
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis.
    Sun W, Zhang Z, Wang J, Shang R, Zhou L, Wang X, Duan J, Ruan B, Gao Y, Dai B, Qu S, Liu W, Ding R, Wang L, Wang D, Dou K.
    Oncotarget; 2016 Mar 08; 7(10):11595-608. PubMed ID: 26871477
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-3194-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by decreasing Wnt/β-catenin signaling through targeting BCL9.
    Yao B, Li Y, Wang L, Chen T, Niu Y, Liu Q, Liu Z.
    Artif Cells Nanomed Biotechnol; 2019 Dec 08; 47(1):3885-3895. PubMed ID: 31561723
    [Abstract] [Full Text] [Related]

  • 18. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
    Song LN, Qiao GL, Yu J, Yang CM, Chen Y, Deng ZF, Song LH, Ma LJ, Yan HL.
    J Exp Clin Cancer Res; 2020 Jun 17; 39(1):114. PubMed ID: 32552766
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
    Zhou W, Zou B, Liu L, Cui K, Gao J, Yuan S, Cong N.
    Oncotarget; 2016 Nov 08; 7(45):74059-74073. PubMed ID: 27677076
    [Abstract] [Full Text] [Related]

  • 20. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W, Chen J, Ding B, Chen D, Zheng H, Jiang D, Xu L, Bao C, Cao G, Fan W.
    J Transl Med; 2018 Sep 29; 16(1):266. PubMed ID: 30268144
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.